title: Drugs for treatment of very high blood pressure during pregnancy.
abstract: BACKGROUND
  Very high blood pressure during pregnancy poses a serious threat to women and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but safety, to avoid complications. Antihypertensive drugs lower blood pressure but their comparative effectiveness and safety, and impact on other substantive outcomes is uncertain.
  
  
  OBJECTIVE
  To compare different antihypertensive drugs for very high blood pressure during pregnancy.
  
  
  METHODS
  We searched the Cochrane Pregnancy and Childbirth Group Trials Register (9 January 2013).
  
  
  METHODS
  Studies were randomised trials. Participants were women with severe hypertension during pregnancy. Interventions were comparisons of one antihypertensive drug with another.
  
  
  METHODS
  Two review authors independently assessed trials for inclusion and assessed trial quality. Two review authors extracted data and checked them for accuracy.
  
  
  RESULTS
  Thirty-five trials (3573 women) with 15 comparisons were included. Women allocated calcium channel blockers were less likely to have persistent high blood pressure compared to those allocated hydralazine (six trials, 313 women; 8% versus 22%; risk ratio (RR) 0.37, 95% confidence interval (CI) 0.21 to 0.66). Ketanserin was associated with more persistent high blood pressure than hydralazine (three trials, 180 women; 27% versus 6%; RR 4.79, 95% CI 1.95 to 11.73), but fewer side-effects (three trials, 120 women; RR 0.32, 95% CI 0.19 to 0.53) and a lower risk of HELLP (haemolysis, elevated liver enzymes and lowered platelets) syndrome (one trial, 44 women; RR 0.20, 95% CI 0.05 to 0.81).Labetalol was associated with a lower risk of hypotension compared to diazoxide (one trial 90 women; RR 0.06, 95% CI 0.00 to 0.99) and a lower risk of caesarean section (RR 0.43, 95% CI 0.18 to 1.02), although both were borderline for statistical significance.Both nimodipine and magnesium sulphate were associated with a high incidence of persistent high blood pressure, but this risk was lower for nimodipine compared to magnesium sulphate (one trial, 1650 women; 47% versus 65%; RR 0.84, 95% CI 0.76 to 0.93). Nimodipine was associated with a lower risk of respiratory difficulties (RR 0.28, 95% CI 0.08 to 0.99), fewer side-effects (RR 0.68, 95% CI 0.55 to 0.85) and less postpartum haemorrhage (RR 0.41, 95% CI 0.18 to 0.92) than magnesium sulphate. Stillbirths and neonatal deaths were not reported.There are insufficient data for reliable conclusions about the comparative effects of any other drugs.
  
  
  CONCLUSIONS
  Until better evidence is available the choice of antihypertensive should depend on the clinician's experience and familiarity with a particular drug; on what is known about adverse effects; and on women's preferences. Exceptions are nimodipine, magnesium sulphate (although this is indicated for women who require an anticonvulsant for prevention or treatment of eclampsia), diazoxide and ketanserin, which are probably best avoided.
authors.affiliation: Nottingham Clinical Trials Unit, Nottingham Health Science Partners, Nottingham, UK. lelia.duley@nottingham.ac.uk
authors.forename: Lelia
authors.initials: L
authors.lastname: Duley
authors.forename: Shireen
authors.initials: S
authors.lastname: Meher
authors.forename: Leanne
authors.initials: L
authors.lastname: Jones
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000188:drug therapy*; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic
chemical_list: D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers
references.citation: Aust N Z J Obstet Gynaecol. 1971 May;11(2):78-84
references.pmid: 5284376
references.citation: Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):160-5
references.pmid: 16253414
references.citation: Ginecol Obstet Mex. 1993 Mar;61:76-9
references.pmid: 8454221
references.citation: BMJ. 2003 Oct 25;327(7421):955-60
references.pmid: 14576246
references.citation: Hypertens Pregnancy. 2009 Aug;28(4):369-82
references.pmid: 19843000
references.citation: Clin Exp Pharmacol Physiol. 2008 May;35(5-6):580-5
references.pmid: 18070142
references.citation: Ann N Y Acad Sci. 2009 Apr;1160:381-4
references.pmid: 19416224
references.citation: BJOG. 2000 Jun;107(6):759-65
references.pmid: 10847232
references.citation: Am J Obstet Gynecol. 1999 Oct;181(4):862-6
references.pmid: 10521743
references.citation: J Perinat Med. 1993;21(1):69-75
references.pmid: 8487154
references.citation: Indian J Med Sci. 1963 Oct;17:812-8
references.pmid: 14069729
references.citation: J Obstet Gynaecol Can. 2008 Mar;30(3 Suppl):S1-S2
references.pmid: 18817592
references.citation: S Afr Med J. 1987 Mar 21;71(6):354-6
references.pmid: 3551127
references.citation: Placenta. 2009 Mar;30 Suppl A:S32-7
references.pmid: 19070896
references.citation: Thromb Haemost. 2004 Feb;91(2):283-9
references.pmid: 14961155
references.citation: Aust N Z J Obstet Gynaecol. 1992 Nov;32(4):335-8
references.pmid: 1290431
references.citation: Obstet Gynecol. 1991 Mar;77(3):331-7
references.pmid: 1992393
references.citation: Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):371-7
references.pmid: 9988803
references.citation: Am J Perinatol. 2010 Sep;27(8):655-62
references.pmid: 20232280
references.citation: Am J Obstet Gynecol. 2002 Oct;187(4):1046-50
references.pmid: 12389003
references.citation: Acta Obstet Gynecol Scand. 1993 Nov;72(8):611-5
references.pmid: 8259746
references.citation: Aust N Z J Obstet Gynaecol. 2009 Jun;49(3):242-6
references.pmid: 19566552
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002252
references.pmid: 17253478
references.citation: Nephrol Dial Transplant. 1998 Feb;13(2):318-25
references.pmid: 9509441
references.citation: Acta Obstet Gynecol Scand. 2002 Jan;81(1):25-30
references.pmid: 11942883
references.citation: Cochrane Database Syst Rev. 2002;(3):CD003106
references.pmid: 12137674
references.citation: Obstet Gynecol. 2006 Apr;107(4):886-95
references.pmid: 16582128
references.citation: N Engl J Med. 2003 Jan 23;348(4):304-11
references.pmid: 12540643
references.citation: J Hum Hypertens. 1999 Mar;13(3):167-71
references.pmid: 10204812
references.citation: Br J Obstet Gynaecol. 1992 Sep;99(9):727-30
references.pmid: 1420010
references.citation: Ginecol Obstet Mex. 1998 Aug;66:316-9
references.pmid: 9745191
references.citation: Am J Obstet Gynecol. 1988 Jan;158(1):80-3
references.pmid: 2962500
references.citation: Br J Obstet Gynaecol. 1991 May;98(5):453-9
references.pmid: 2059591
references.citation: Acta Obstet Gynecol Scand. 1992 Jan;71(1):22-7
references.pmid: 1315092
references.citation: Int J Gynaecol Obstet. 1995 Jun;49(3):265-9
references.pmid: 9764864
references.citation: Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):157-62
references.pmid: 16621226
references.citation: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD000025
references.pmid: 21069663
references.citation: Eur J Obstet Gynecol Reprod Biol. 2006 Jul;127(1):61-7
references.pmid: 16243427
references.citation: J Obstet Gynaecol. 1999 May;19(3):235-8
references.pmid: 15512286
references.citation: Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):279-85
references.pmid: 17627681
references.citation: Aust N Z J Obstet Gynaecol. 1986 Feb;26(1):26-9
references.pmid: 3524548
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001449
references.pmid: 16855969
references.citation: Pregnancy Hypertens. 2012 Jul;2(3):182
references.pmid: 26105228
references.citation: Medscape Womens Health. 2002 Sep-Oct;7(5):1
references.pmid: 12466730
references.citation: Am J Hypertens. 1999 Apr;12(4 Pt 1):341-7
references.pmid: 10232493
references.citation: Intensive Care Med. 2002 Sep;28(9):1281-6
references.pmid: 12209278
references.citation: Postgrad Med J. 1983;59 Suppl 3:168-70
references.pmid: 6647203
references.citation: Cochrane Database Syst Rev. 2000;(2):CD001805
references.pmid: 10796272
references.citation: Zentralbl Gynakol. 2001 Sep;123(9):529-33
references.pmid: 11709746
references.citation: Am J Obstet Gynecol. 1993 Apr;168(4):1292-6
references.pmid: 8475977
references.citation: Clin Exp Hypertens. 2008 Nov;30(8):744-66
references.pmid: 19021025
references.citation: Int J Gynaecol Obstet. 2002 Feb;76(2):135-41
references.pmid: 11818107
references.citation: Am J Obstet Gynecol. 1999 Oct;181(4):858-61
references.pmid: 10521742
references.citation: J Perinatol. 2009 Apr;29(4):284-9
references.pmid: 19148110
references.citation: J Crit Care. 2009 Dec;24(4):551-5
references.pmid: 19327948
references.citation: Cochrane Database Syst Rev. 2010 Sep 08;(9):CD002960
references.pmid: 20824833
references.citation: Pregnancy Hypertens. 2012 Jul;2(3):287-8
references.pmid: 26105409
references.citation: Ultrasound Med Biol. 2011 Jan;37(1):53-8
references.pmid: 21084154
references.citation: Zhonghua Fu Chan Ke Za Zhi. 2000 Mar;35(3):151-2
references.pmid: 11775892
references.citation: J Obstet Gynaecol Res. 1996 Feb;22(1):21-4
references.pmid: 8624887
references.citation: Cir Cir. 2004 May-Jun;72(3):203-7
references.pmid: 15310446
references.citation: S Afr Med J. 1984 Feb 25;65(8):279-80
references.pmid: 6695297
references.citation: Br J Obstet Gynaecol. 1998 Jul;105(7):723-31
references.pmid: 9692412
references.citation: S Afr Med J. 1989 Sep 16;76(6):248-50
references.pmid: 2781421
references.citation: Gynecol Obstet Invest. 2000;50(1):39-42
references.pmid: 10895027
references.citation: BJOG. 2012 Jan;119(1):78-85
references.pmid: 21985500
references.citation: Eur J Obstet Gynecol Reprod Biol. 1997 Dec;75(2):155-9
references.pmid: 9447368
references.citation: Acta Med Iran. 2011;49(11):701-6
references.pmid: 22131238
references.citation: Cochrane Database Syst Rev. 2000;(2):CD001449
references.pmid: 10796261
references.citation: Semin Thromb Hemost. 2003 Dec;29(6):645-52
references.pmid: 14719181
references.citation: Obstet Gynecol. 1987 Sep;70(3 Pt 1):328-33
references.pmid: 3306494
references.citation: J Am Soc Hypertens. 2008 Nov-Dec;2(6):484-94
references.pmid: 20409930
references.citation: Cochrane Database Syst Rev. 2010 Sep 08;(9):CD008148
references.pmid: 20824872
references.citation: Med Hypotheses. 2004;63(2):239-44
references.pmid: 15236782
references.citation: Thromb Haemost. 2000 Oct;84(4):583-90
references.pmid: 11057854
references.citation: Clin Exp Hypertens B. 1982;1(2-3):371-83
references.pmid: 7139977
references.citation: Eur J Obstet Gynecol Reprod Biol. 2002 May 10;102(2):161-6
references.pmid: 11950484
references.citation: Am J Obstet Gynecol. 1999 Aug;181(2):402-7
references.pmid: 10454691
references.citation: BJOG. 2011 Mar;118 Suppl 1:1-203
references.pmid: 21356004
references.citation: Hypertens Pregnancy. 2011;30(2):144-52
references.pmid: 20818967
references.citation: Curr Hypertens Rep. 2003 Aug;5(4):288-9
references.pmid: 12918532
references.citation: Thromb Haemost. 2011 Dec;106(6):1053-61
references.pmid: 21946915
references.citation: S Afr Med J. 1995 Jun;85(6):525-8
references.pmid: 7652635